Sotigalimab Antibody
Sotigalimab (APX005M) is a CD40-targeting monoclonal antibody developed for cancer immunotherapy research. It has demonstrated potential antitumor activity in preclinical studies, including in vitro assays and in vivo models of metastatic pancreatic ductal adenocarcinoma and melanoma, by modulating immune responses.
Product Specifications
Product Name Alternative
PYX107, PYX-107, EPI-0050, APX 005, APX 005M, APX005
Target
TNF
Clonality
Monoclonal
Conjugation
Unconjugated
Field of Research
Cell Biology
Concentration
9.95 mg/mL
Purity
98.50% (May vary between batches)
Molecular Weight
144.35 kDa
Storage Conditions
Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.
Notes
For research use only.
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog